Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

A randomized controlled study of immunochemotherapy with OK-432 after curative surgery for gastric cancer.

A randomized controlled study of immunochemotherapy with OK-432 after curative surgery for gastric cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • A randomized controlled study of immunochemotherapy with OK-432 after curative surgery for gastric cancer. Abstract Text:

    The effect of adjuvant immunochemotherapy including OK-432 (Picibanil) on survival was assessed in patients who underwent curative resection of gastric cancer. Patients enrolled in this randomized controlled study were randomly assigned to group A or group B. Group A patients received 800 mg/d 5'-DFUR (Furtulon) for 2 years from 2 weeks after the operation. Group B patients received OK-432 plus 5'-DFUR by the same regimen as in group A. This study enrolled 288 patients, and 1 patient with malignant lymphoma was excluded. Among the remaining 287 patients, 143 and 144 were allocated to group A and group B, respectively, and their data were included in statistical analysis. The 5-year survival rates for groups A and B were 62.9% and 63.8%, respectively, showing no significant difference (P = 0.7996).

    A randomized controlled study of immunochemotherapy with OK-432 after curative surgery for gastric cancer. Publishing Authors By Initials

    For similar investigative techniques: epidemiologic methods: statistics as topic: survival analysis research abstracts see: investigative techniques: epidemiologic methods: statistics as topic: survival analysis research

    PUBMED ID PMID:

    MEDLINE DATE: 2004 Sep-Oct

    A randomized controlled study of immunochemotherapy with OK-432 after curative surgery for gastric cancer. Journal Published:

    PUBLICATION TYPE: Randomized Controlled Trial

    Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

    VOLUME: 27

    Page Numbers: 394-7

    Journal Abbreviation: J. Immunother.

    ISSN: 1524-9557

    DAY: 18

    MONTH: 03

    YEAR: 2008

    A randomized controlled study of immunochemotherapy with OK-432 after curative surgery for gastric cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9706083

    A randomized controlled study of immunochemotherapy with OK-432 after curative surgery for gastric cancer. Keywords Mesh Terms:

    KEYWORDS: Survival Analysis

    MESH TERMS: mortality

    Chemical & Substance for Abstract: A randomized controlled study of immunochemotherapy with OK-432 after curative surgery for gastric cancer. Information

    Substance Name: Floxuridine

    Registry Number: 50-91-9

    Grant and Affiliation Information for A randomized controlled study of immunochemotherapy with OK-432 after curative surgery for gastric cancer.

    AFFILIATION: First Department of Surgery, School of Medicine, Hokkaido University, Sapporo, Japan. yuchan@med.hokudai.ac.jp

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Immunother

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    A randomized controlled study of immunochemotherapy with OK-432 after curative surgery for gastric cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News